The Board of Directors of Analabs wishes to announce that the present mandate granted by the shareholders of the Company at the Annual General Meeting ("AGM") held on 4 October 2019 to buy back its own shares will expire at the conclusion of the forthcoming 22nd AGM.
In this regard, the Company proposes to seek from its shareholders at the forthcoming 22nd AGM to be convened, a renewal of authority to purchase up to a maximum of ten per centum (10%) of the issued share of the Company comprising of 108,954,000 ordinary shares (excluding treasury shares).
A Statement to Shareholders detailing the Proposed Share Buy-Back will be despatched to the shareholders of the Company in due course.
This announcement is dated 25 June 2020.